Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy. - Zhang Z; Sehgal K; Shirai K; Butler RA; Wiencke JK; Koestler DC; Ramush G; Lee MK; Molinaro AM; Stolrow HG; Birnbaum A; Salas LA; et al. (NPJ precision oncology, 2024)